Adding tirzepatide to insulin glargine ups glycemic control in type 2 diabetes mellitus
Feb 10, 2022
For adults with type 2 diabetes and inadequate glycemic control, glycemic control improved with the addition of tirzepatide versus placebo.
Rural residents more fatalistic about cancer
Feb 09, 2022
Additionally, rural residents show greater information overload.
Dry powder inhalers show benefits for asthma control, environment
Feb 08, 2022
Switching to a dry powder inhaler more than halves the carbon footprint of asthma treatment without asthma worsening.
Deaths prevented with increasing physical activity quantified
Feb 04, 2022
Decreases of 6.9, 13 and 16.9% were seen in the number of deaths per year with increases of 10, 20 or 30 minutes moderate-to-vigorous physical activity/day, respectively.
Trials show promise for intravitreal faricimab in retinal disease
Feb 02, 2022
Faricimab was noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration and diabetic macular edema.
Midlife cardiac structure and its change linked to cognition
Feb 02, 2022
A 25-year increase in left ventricular mass was linked to lower cognition on most tests; an increase in LAV was linked to lower global cognition.
Prevalence of melatonin supplement use increased over time
Feb 01, 2022
1999-2000 to 2017-2018 saw an increase in reported prevalence of melatonin use across sex and age groups. A concern is that products sometimes contain more of the ingredient than specified on the label.
Remdesivir offers some benefit for hospitalized COVID-19 patients
Feb 01, 2022
No difference was seen for in-hospital mortality, but a need for initiation of mechanical ventilation was reduced with the addition of remdesivir to standard care.
SARS-CoV-2 antibody tests should not be used for diagnosis
Feb 01, 2022
A related review shows that recent infection protected against symptomatic reinfection with the wild-type or alpha variant of SARS-CoV-2.
‘Stealth’ version of omicron variant no cause for alarm, experts say
Jan 31, 2022
The new version of the variant does not appear to cause more severe disease, and vaccines are effective against it.